104 related articles for article (PubMed ID: 2847323)
1. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
Wu AY; Lau YK; Chia KB; Lim CH
Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
[No Abstract] [Full Text] [Related]
2. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
3. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
[No Abstract] [Full Text] [Related]
4. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
Desgranges C; de-The G
IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
[No Abstract] [Full Text] [Related]
5. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
[No Abstract] [Full Text] [Related]
6. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
Gunvén P; Klein G; Henle W; Henle G; Forsby N
Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
[TBL] [Abstract][Full Text] [Related]
7. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
Caliceti U; Cevenini R; Donati M
Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
[No Abstract] [Full Text] [Related]
8. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
9. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
11. IgA and nasopharyngeal carcinoma.
Desgranges C; De-The G
IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
[No Abstract] [Full Text] [Related]
12. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
Tang ZH
Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
[No Abstract] [Full Text] [Related]
13. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
14. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
Shang M
Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
[No Abstract] [Full Text] [Related]
15. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
Tang ZH
Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
[No Abstract] [Full Text] [Related]
16. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
Liu YX; Zeng Y; Dong WP; Cao GR
Zhonghua Zhong Liu Za Zhi; 1979; 1(1):8-12. PubMed ID: 233233
[No Abstract] [Full Text] [Related]
17. [Relation between the growth pattern and the quantity of plasma cells of nasopharyngeal cancer (NPC) and serum EBV antibody level].
Li JT
Zhonghua Zhong Liu Za Zhi; 1985 Jan; 7(1):9-11. PubMed ID: 2983963
[No Abstract] [Full Text] [Related]
18. [125I] Clq-binding activity and its relationship with anti-Epstein--Barr virus antibodies in sera from nasopharyngeal carcinoma patients.
Lamelin JP; Vincent C; Souissi T; Revillard JP
Eur J Cancer (1965); 1979 Feb; 15(2):163-71. PubMed ID: 220051
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
Kottaridis SD; Goula I; Kiparissiadis P
Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
[No Abstract] [Full Text] [Related]
20. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
Henle W; Ho JH; Henle G; Chau JC; Kwan HC
Int J Cancer; 1977 Nov; 20(5):663-72. PubMed ID: 200569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
